Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-06-16
1994-10-11
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540547, C07D41306, A61K 3155
Patent
active
053547470
ABSTRACT:
The present invention provides substituted dibenzoxazepine and dibenzthiazepine compounds of Formula I: ##STR1## which are useful as analgesic agents for the treatment of pain, and for prostaglandin-E.sub.2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal, and a method for treating prostaglandin-E.sub.2 mediated diseases in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
REFERENCES:
patent: 2852528 (1958-09-01), Hoffmann
patent: 3210372 (1965-10-01), Harvey
patent: 3357998 (1967-12-01), Cusic
patent: 3419554 (1968-12-01), Bernstein
patent: 3452046 (1969-06-01), Yale et al.
patent: 3534019 (1970-10-01), Coyne
patent: 3624104 (1971-11-01), Cusic
patent: 3644346 (1972-02-01), Cusic
patent: 3917649 (1975-11-01), Mueller
patent: 3989719 (1976-11-01), Mueller
patent: 3992375 (1976-11-01), Mueller
patent: 4045442 (1977-08-01), Mueller
patent: 4125532 (1978-11-01), Mueller
patent: 4170593 (1979-10-01), Mueller
patent: 4221715 (1980-09-01), Mckenzie
patent: 4290953 (1981-09-01), Koizumi
patent: 4360525 (1982-11-01), Muller
patent: 4379150 (1983-04-01), Ito
patent: 4434171 (1984-02-01), Muller
patent: 4559336 (1985-12-01), Mueller
patent: 4559337 (1985-12-01), Mueller
patent: 4614617 (1986-09-01), Mueller
patent: 4681939 (1987-07-01), Mueller
patent: 4704386 (1987-11-01), Mueller
patent: 5121169 (1993-05-01), Husa et al.
patent: 5180720 (1993-01-01), Husa
patent: 5182272 (1993-01-01), Hallinan
patent: 5225417 (1993-07-01), Dappen et al.
patent: 5281590 (1994-01-01), Husa et al.
patent: 5283240 (1994-02-01), Hallinan et al.
patent: 5288719 (1994-02-01), Husa et al.
patent: 5304644 (1994-04-01), Husa et al.
A. Bennett et al. "Antagonism of Prostanoid-Induced Contractions of Rat Gastric Fundus Muscle by SC-19220 Sodium Meclofenamate, Indomethacin or Trimethoquinol," Br. J. Pharmac., 71, 169-175 (1980)-London.
Hach et al, Chemical Abstract 52:4652: (1957).
Jilek et al, Chem. Abstract 62:14707h-147089 (1964).
W. E. Coyne, et al. "Anticonvulsant Semicarbazides," J. Med. Chem., 11(6), 1158-1160 (1968)-USA.
E. J. Drower, et al. "The Antiociceptive Effects of Prostaglandin Antagonists in the Rat," European Journal of Pharmacology, 133, 249-256 (1987)-Europe.
F. R. George, et al. "Antagonism of Alcohol Hypnosis by Blockade of Prostaglandin Synthesis and Activity: Genotype and Time Course Effects," Pharmacology, Biochemistry & Behavior, vol. 19, 131-136 (1983)-USA.
R. Gimet, et al. "Quantitative Determination of Polymorphic Forms in a Formulation Matrix Using the Near Infra-Red Reflectance Analysis Technique," Journal of Pharmaceutical & Biomedical Analysis, vol. 5, No. 3, 205-211 (1987)-Great Britain.
A. Gomes, et al. "Pharmacodynamics of Venom of the Centipede Scolopendra Subspinipes Dehaani," Indian Journal of Experimental Biology, vol. 20, 615-618, Aug. (1982)-India.
K. Gyrires, et al. "The Use of the Writhing Test in Mice for Screening Different Types of Analgesics," Arch. Int. Pharmacodyn, 267, 131-140 1984)-USA.
D. E. MacIntyre, et al. "Antagonism of Human Platelet Responses to Stimulatory and Inhibitory Prostaglandins," Prog. Lipid. Res., 20 (1-4), 453-9 (1981) -USA.
C. A. Maggi, et al. "The Effect of SC-19220, a Prostaglandin Antagonist, on the Micturition Reflex in Rats," European Journal of Pharmacology, 152, 273-279 (1988)-Europe.
K. Nagarajan, et al. "Synthesis of 10,11-Dihydrodibenz[b,f][1,4]oxazepine Derivatives as Potential Anticonvulsant & Psychotropic Agents," Indian Journal of Chemistry, vol. 24B, 840-844 (1985) -India.
S. Nakejyo, et al. "Inhibitory Effect of Bassianolide, A Cyclodepsipeptide, on Drug-Induced Contractions of Isolated Smooth Muscle Preparations," Japan J. Pharmacol., 32, 55-64 (1982)-Japan.
A. Rakovska, et al. "Antagonistic Effect of SC-19220 on the Responses of Guinea-Pig Gastric Muscles to Prostaglandins E.sub.1, E.sub.2, and F.sub.2a," Arch. Int. Pharmacodyn., 268, 59-69 (1984)-USA.
J. H. Sanner "Dibenzoxazepine Hydrazides as Prostaglandin Antagonists," Intra-Science Chem. Rept., vol. 6, No. 1, 1-9 (1972)-USA.
J. H. Sanner, et al. "Structure-Activity Relationships of Some Dibenzoxazepine Derivatives as Prostaglandin Antagonists," Advances in the Biosciences, 9, 139-148 (1972)-USA.
M. E. Grieg, etal. "Effects of a Group of Dibenzoxazepines on Fatal Systemic Analphylaxis in Mice, Rats, and Guinea Pigs," Journal of Medicinal Chemistry, vol. 14, No. 2, 153-156 (1971)-USA.
U.S. patent application Ser. No. 07/813,316, filed Dec. 20, 1991 by Hagen.
U.S. patent application Ser. No. 08/021,694 filed Jan. 24, 1993 by Dappen.
U.S. patent application Ser. No. 08/056,704 filed Apr. 30, 1993 by Chandrakumar.
U.S. patent application Ser. No. 08/069,503 filed May 28, 1993 by Chandrakumar.
Hansen, Jr. Donald W.
Peterson Karen B.
Datlow Philip I.
G. D. Searle & Co.
Hastreiter Roberta L.
Shah Mukund J.
Williams Roger A.
LandOfFree
2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxaze does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxaze, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxaze will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658722